![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Biophore India Pharmaceuticals Pvt. Ltd. Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
They are recognized for Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
One of their significant offerings is Valsartan, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-097 - Rev 00
This Chemical Type CEP, issued on February 09, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2423 associated with this CEP further emphasizes